Almac expands commercial capabilities to meet industry demand for paediatric formulations
The acquisition reflects growing demand for the specialist packaging solutions for powders, minitabs or granules into stickpack sachets.
Almac Group has expanded its MHRA/FDA-approved UK commercial packaging facility with the acquisition of a stick sachet packaging line from Merz.
The acquisition comes in response to growing demand for the specialist packaging solutions for paediatric drug products, specifically powders, minitabs or granules into stickpack sachets. This investment was made in partnership with a long-term commercial US client who having worked with Almac since 2010, now sought an integrated commercial manufacturing and packaging solution for the EU supply of their new paediatric formulation drug product.
In line with EU Paediatric Regulations (EC1901/2006 and EC1902/2006), the US client implemented its Paediatric Investigation Plan (PIP) and developed and launched an age appropriate formulation to meet infant patient needs; with Almac manufacturing the paediatric granules, primary packing into stickpack sachets and then into wallet cards.
To facilitate the packaging of paediatric dosage forms, investment was made in Merz Stickpack technology. The SBL-50 stickpack technology is a fully automated forming, filling and sealing machine capable of filling 80 stickpacks/minute. This flexible technology not only meets the stickpack presentation needs of Almac’s current clients, it also has capacity to process new paediatric drug products (powders, granules and minitabs) that require this specialist packaging.
David Downey, VP Commercial Operations at Almac commented: “Almac continue to expand our commercial packaging capabilities and the addition of this stickpack solution strengthens Almac’s position in providing flexible services to meet various market needs from small volume orphan drug products to large scale marketed products in both adult and paediatric forms.”
Holger Merz, General Manager at Merz said: “The innovative and committed team at Almac set up a compact, highly flexible packaging solution for micro tablets and powders in stickpacks to service the growing demand for this user-friendly dosage form. Advanced primary packaging forms like stickpacks offer highest flexibility for diversification of pharmaceutical products.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.